Arecor Therapeutics appoints Simon Ormiston to its Board as Non-Executive Director

– UK, Cambridge –  Arecor Therapeutics plc (LON: AREC), the biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic diseases, announced the appointment of Simon Ormiston to its Board as a Non-Executive Director and the new Chair of the Audit & Risk Committee, with immediate effect.…